Protease Inhibition: Design, Technology & Opportunities--First RSC/SCI Symposium on Protease Inhibition.18-19 May
1DRB Associates, 18 Hillfield Road, Redhill, Surrey, RH1 4AP, UK. Derek.Buckle@ndirect.co.uk
Idrugs : the Investigational Drugs Journal
|May 10, 2008
Summary
This symposium focused on proteolytic enzymes, their classification, structure, and mechanisms. It highlighted methods for developing potent and selective inhibitors for various therapeutic targets.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Enzymology
Background:
- Proteolytic enzymes play crucial roles in biological processes.
- Dysregulation of proteolytic enzymes is implicated in numerous diseases.
- Developing selective inhibitors is a key challenge in drug discovery.
Purpose of the Study:
- To review current knowledge on proteolytic enzyme classification, structure, and mechanism.
- To discuss methodologies for identifying potent and selective enzyme inhibitors.
- To present a range of therapeutic targets across all proteinase classes.
Main Methods:
- Symposium format featuring presentations and discussions.
- Focus on medicinal chemistry approaches and methodologies.
- Targeted review of therapeutic areas involving proteolytic enzymes.
Main Results:
- Consolidated current understanding of proteolytic enzyme characteristics.
- Highlighted effective strategies for inhibitor development.
- Showcased diverse therapeutic targets for medicinal chemists.
Conclusions:
- Advancements in understanding proteolytic enzymes facilitate inhibitor design.
- Medicinal chemistry plays a vital role in developing targeted therapies.
- Continued research is essential for addressing diseases linked to proteolytic enzymes.
Related Concept Videos
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
02:04Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...